lysogene.com-lysogene - biotechnology company in the field of gene therapy

Données techniques du lysogene.com

Geo IP vous fournit comme la latitude, la longitude et l'ISP (Internet Service Provider) etc. informations. Notre service GeoIP a trouvé l'hôte lysogene.com.Actuellement, hébergé dans France et son fournisseur de services est OVH SAS .

Latitude:	50.69421005249
Longitude:	3.1745600700378
Pays:	France (fr)
Ville:	Roubaix
Région:	Nord-Pas-de-Calais
ISP:	OVH SAS

the related websites

domaine	Titre
lysogene.com	lysogene - biotechnology company in the field of gene therapy
quantum-genomics.fr	quantum-genomicsfr - Global biotechnology company
inatherys.com	inatherys, biotechnology company : monoclonal antibodies
quantum-genomics.com	quantum genomics corp. (qgc) - global biotechnology company
jcebiotechnology.com	jce-biotechnology isolateurs sur mesure
bio.org	biotechnology innovation organization
toulouse-white-biotechnology.com	accueil - toulouse white biotechnology
carlinatech.com	carlina technologies - biotechnology - development of nanomedicines
biocydex.net	pharmaceutical research & cyclodextrin biotechnology developer - biocydex
choisy.com	choisy \| professional hygiene products \| us/canada \| chemistry and biotechnology
eurostartentreprises.com	company formation france & europe \| euro start entreprises \| open a company fra
company.fm	company.fm - the huge database of the world's companies, list your company now
cogitaxis.com	seo company in chennai \| best search engine optimization (seo) company in chenna
companycheck.co.uk	company check \| free company & director information & reports
sujataassociates.com	register a company - company registration process - company registration

cnrtl.fr

universalis.fr

ecosociosystemes.fr

cours-de-biochimie.fr

sites.crdp-aquitaine.fr

rdmo.fr

Analyse d'en-tête HTTP

Les informations d'en-tête HTTP font partie du protocole HTTP que le navigateur d'un utilisateur envoie à appelé Apache/2.4.12 (FreeBSD) PHP/5.5.22 contenant les détails de ce que le navigateur veut et acceptera de nouveau du serveur Web.

X-PgCache-time:	2018-08-06 17:01:37
Content-Length:	6241
X-Powered-By:	PHP/5.5.22
X-PgCache-size:	6241
Content-Encoding:	gzip
Keep-Alive:	timeout=5, max=100
Server:	Apache/2.4.12 (FreeBSD) PHP/5.5.22
X-Compression:	gzip
X-PgCache-hit:	VALID
Connection:	Keep-Alive
Cache-Control:	no-cache no-store must-revalidate
Date:	Tue, 07 Aug 2018 15:12:47 GMT
X-Frame-Options:	DENY
Content-Type:	text/html

DNS

soa:	dns108.ovh.net. tech.ovh.net. 2018010300 86400 3600 3600000 300
txt:	"v=spf1 a a:webprod.lysogene.com a:webpreprod.lysogene.com a:mail.lysogene.com -all"
ns:	ns108.ovh.net. dns108.ovh.net.
ipv4:	IP:5.135.223.154 ASN:16276 OWNER:OVH, FR Country:FR
mx:	MX preference = 30, mail exchanger = filter999.zerospam.ca. MX preference = 20, mail exchanger = filter3972.zerospam.ca. MX preference = 10, mail exchanger = filter3971.zerospam.ca.

HtmlToText

contact us en fr about us our history expertise management board of directors scientific advisors rare diseases policy transparency pioneering science concept pipeline clinical programs mps iiia gm1 gangliosidosis patients and families mps iiia gm1 gangliosidosis links and resources partnering investors welcome stock information press releases events amf regulated information annual general assembly 2017 annual general assembly 2018 corporate presentation investor contacts media pioneering gene therapies for cns disorders committed to making an extraordinary difference in patients’ lives on the cutting edge of cns gene therapy science lysogene is a pioneer in the basic research and clinical development of gene therapy for neurodegenerative disorders . our mission is to radically improve the health of patients suffering from incurable life threatening conditions. we do this by developing aav vectors that have demonstrated their effectiveness in safely delivering genetic material to the central nervous system. news 01 aug 2018 lysogene announces upcoming presentations at the 2018 international mps symposium 23 jul 2018 lysogene reports second quarter cash position and provides business and strategic update see all news in the clinic mps iiia lysogene successfully completed its phase i/ii clinical trial of gene therapy in mps iiia and plans its phase ii/iii registrational trials ... read more gm1 gangliosidosis lysogene develops ind-supporting preclinical studies and plans its phase i/ii clinical trial of gene therapy in gm1 gangliosidosis ... read more latest tweet rt @francebiotech : "aujourd'hui, lysogène est la seule biotech au monde dans le domaine de la thérapie génique à entrer en phase 3 dan… https://t.co/jg1iv4mtzb get in touch contact us follow us join our mailing list ok copyright © 2010-2015 lysogene contact us sitemap terms of use arrow-left arrow-right calendar contact download facebook linkedin location play reset rss twitter youtube

Analyse PopURL pour lysogene.com

http://www.lysogene.com/in-the-media-3/
http://www.lysogene.com/patients-and-families/gm1-gangliosidosis/
http://www.lysogene.com/about/our-history/
http://www.lysogene.com/clinical-programs/mps-iiia-phase-i/
http://www.lysogene.com/pioneering-science/pipeline/
http://www.lysogene.com/about/transparency/
http://www.lysogene.com/media-center/investor-contacts/
http://www.lysogene.com/about/management-team/
http://www.lysogene.com/media-center/news/lysogene-reports-second-quarter-cash-position-and-provides-business-and-strategic-update/
http://www.lysogene.com/about/rare-diseases-policy/
http://www.lysogene.com/media-center/financial-information/
http://www.lysogene.com/about/board-of-directors/
http://www.lysogene.com/patients-and-families/mps-iiia/
http://www.lysogene.com/clinical-programs/gm1-phase-i/
http://www.lysogene.com/about/advisors/

Informations Whois

Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;

Domain Name: LYSOGENE.COM
Registry Domain ID: 1605003735_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.ovh.com
Registrar URL: http://www.ovh.com
Updated Date: 2016-10-20T05:00:28Z
Creation Date: 2010-07-04T15:46:25Z
Registry Expiry Date: 2018-07-04T15:46:25Z
Registrar: OVH
Registrar IANA ID: 433
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: DNS108.OVH.NET
Name Server: NS108.OVH.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-08-18T08:44:48Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR OVH

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =lysogene.com

  PORT 43

  TYPE domain
RegrInfo
DOMAIN

  NAME lysogene.com

  CHANGED 2016-10-20

  CREATED 2010-07-04

STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited

NSERVER

  DNS108.OVH.NET 213.251.188.152

  NS108.OVH.NET 213.251.128.152

  REGISTERED yes

Go to top

lysogene.com rapport : Visitez le site